Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
I owned shares of (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar over 60% in roughly two years was fun. Seeing Pfizer's share price fall nearly 60% from its peak wasn't so fun.
Have I been tempted to sell during this major decline? Nope. Instead, I'm buying this beaten-down, high-yield dividend stock hand over fist.
It's understandable why Pfizer stock has fallen so much. The drugmaker has faced some big challenges and has more on the way.
Source Fool.com